Key Takeaways
- Noho is changing the lives of people suffering from lymphedema, typically a lifelong condition.
- Based in Brussels, Noho uses cloud technology and IoT to facilitate at-home treatment.
- The company’s product is reducing reliance on practitioners, offering freedom and cost savings to patients.
- Strong collaboration and support from Brussels educational and medical institutions aided in product development.
Introduction
Belgium-based startup Noho is placing individuals with lymphedema in control of their treatment using innovative cloud technology and Internet of Things (IoT) devices. Lymphedema, a chronic condition characterized by swelling in the body due to a blocked lymphatic system, typically requires a lifetime of treatment involving multi-layer compression bandages applied by specialized practitioners. This can mean weekly visits to healthcare providers, a significant cost both financially and in terms of personal freedom.
Through their cloud-based system, Noho enables individuals to treat their condition anytime, anywhere, reducing reliance on a third party. The aim is not just clinical efficiency but an improved quality of life for patients, enabling them to manage their condition independently and reducing social stigma.
Differentiating Factors
Unique to Noho’s approach is the patient’s ability to self-treat their lymphedema, guided by IoT technology. The IoT device communicates with the cloud-based system, giving the patient real-time feedback and the practitioner a remote overview of the patient’s condition. Furthermore, the efficiency of Noho’s system has been tested in clinical trials, demonstrating its viability.
Another standout factor in Noho’s operation is the company’s collaboration with respected Belgian institutions. The product is developed in partnership between the Ecole Polytechnique de Bruxelles and the Clinique de Lymphologie de Bruxelles, a clinic treating over 1,000 lymphedema patients a month. For additional support, the Brussels Institute for Research and Innovation, known as Innoviris, provided financial backing for product development.
Conclusion and Future Outlook
As a company transforming lymphedema treatment through cloud technology, Noho is only in its early stages. The implications of their product, however, are far-reaching. Not only does it pave the way for more independent management of chronic health conditions, but it also reduces healthcare costs and increases access to therapy for patients who may be unable to frequently visit healthcare providers.
This approach positions Noho at the forefront of digital health advancements, particularly within the mHealth industry. As technology continues to evolve, it will be interesting to see how Noho expands the application of their product and whether similar models begin to emerge in the treatment of other health conditions. To keep up with Noho, follow their updates on Website, Twitter, Facebook, and LinkedIn.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
